These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20497617)

  • 1. At last, a predictive and prognostic marker for radiotherapy?
    Coates P; Dewar J; Thompson AM
    Breast Cancer Res; 2010; 12(3):106. PubMed ID: 20497617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
    Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
    Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells.
    Serafim RB; Cardoso C; Di Cristofaro LFM; Pienna Soares C; Araújo Silva W; Espreafico EM; Paçó-Larson ML; Price BD; Valente V
    Cancer Gene Ther; 2020 May; 27(5):319-329. PubMed ID: 31138900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients.
    Sterpone S; Cornetta T; Padua L; Mastellone V; Giammarino D; Testa A; Tirindelli D; Cozzi R; Donato V
    Mutat Res; 2010 Feb; 684(1-2):43-8. PubMed ID: 19962393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.
    Montes de Oca R; Gurard-Levin ZA; Berger F; Rehman H; Martel E; Corpet A; de Koning L; Vassias I; Wilson LO; Meseure D; Reyal F; Savignoni A; Asselain B; Sastre-Garau X; Almouzni G
    Mol Oncol; 2015 Mar; 9(3):657-74. PubMed ID: 25497280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer.
    Tanić M; Krivokuća A; Čavić M; Mladenović J; Plesinac Karapandžić V; Beck S; Radulović S; Susnjar S; Janković R
    Radiat Oncol; 2018 Oct; 13(1):193. PubMed ID: 30285791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAS Death Receptor: A Breast Cancer Subtype-Specific Radiation Response Biomarker and Potential Therapeutic Target.
    Horton JK; Siamakpour-Reihani S; Lee CT; Zhou Y; Chen W; Geradts J; Fels DR; Hoang P; Ashcraft KA; Groth J; Kung HN; Dewhirst MW; Chi JT
    Radiat Res; 2015 Nov; 184(5):456-69. PubMed ID: 26488758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for genetic determinants of normal tissue radiosensitivity--are we on the right track?
    Andreassen CN
    Radiother Oncol; 2010 Oct; 97(1):1-8. PubMed ID: 20817285
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.
    Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy.
    Twardella D; Popanda O; Helmbold I; Ebbeler R; Benner A; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Chang-Claude J
    Radiother Oncol; 2003 Nov; 69(2):145-53. PubMed ID: 14643951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Holliday junction recognition protein as a prognostic biomarker and therapeutic target for oral cancer.
    Tsevegjav B; Takano A; Zhu M; Yoshitake Y; Shinohara M; Daigo Y
    Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35103286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer.
    Jiang Y; Liu Y; Hu H
    Adv Exp Med Biol; 2017; 1026():105-123. PubMed ID: 29282681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.
    Terrazzino S; La Mattina P; Gambaro G; Masini L; Franco P; Canonico PL; Genazzani AA; Krengli M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):504-11. PubMed ID: 22079734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a radiosensitivity gene signature for Caucasian patients with breast cancer.
    Ji Y; Jiang Q; Jian G; Sun H; Wang Y; Qin H; Zhang S; Cao J; Tang Z
    Oncol Rep; 2018 Sep; 40(3):1695-1705. PubMed ID: 30015959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
    Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
    Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Expression of Holliday Junction-Recognizing Protein (HJURP) as an Independent Prognostic Biomarker in Advanced-Stage Serous Ovarian Carcinoma.
    Li L; Li X; Meng Q; Khan AQ; Chen X
    Med Sci Monit; 2018 May; 24():3050-3055. PubMed ID: 29743473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA repair and apoptosis: Roles in radiotherapy-related acute reactions in breast cancer patients.
    Batar B; Mutlu T; Bostanci M; Akin M; Tuncdemir M; Bese N; Guven M
    Cell Mol Biol (Noisy-le-grand); 2018 Mar; 64(4):64-70. PubMed ID: 29631685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 Mutation: A Predictive Marker for Radiation Therapy?
    Kan C; Zhang J
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):281-93. PubMed ID: 26383678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells.
    Kato T; Sato N; Hayama S; Yamabuki T; Ito T; Miyamoto M; Kondo S; Nakamura Y; Daigo Y
    Cancer Res; 2007 Sep; 67(18):8544-53. PubMed ID: 17823411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.